Clinical Trials Browser

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT05027204 2022-10-13

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

Phase 1/2 Unknown

94 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05235542 2022-08-11

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Phase 1/2 Unknown

130 enrolled

Advanced Malignant Tumors

NCT05173142 2022-03-08

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

Phase 1/2 Unknown

141 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03726736 2019-06-07

ACWDVDFPTAN

Phase 1/2 Unknown

97 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02450656 2018-08-27

M14AFS

Phase 1/2 Unknown

320 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02884479 2018-04-25

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Phase 1/2 Unknown

75 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00002775 2014-01-06

Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Phase 1/2 Unknown

37 enrolled

Genitourinary

Prostatic Neoplasms

NCT00004264 2013-12-04

Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 1/2 Unknown

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00982436 2012-03-22

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

Phase 1/2 Unknown

37 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00821912 2012-02-28

TaxXel

Phase 1/2 Unknown

93 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00845884 2009-02-18

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Phase 1/2 Unknown

49 enrolled

Tumor-Agnostic

Neoplasms

NCT00448734 2009-01-21

A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer

Phase 1/2 Unknown

95 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00075543 2008-07-24

Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Phase 1/2 Unknown

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00379717 2008-03-13

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00121095 2007-12-21

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Phase 1/2 Unknown

69 enrolled

Genitourinary

Prostatic Neoplasms

NCT00082472 2006-04-18

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Phase 1/2 Unknown

30 enrolled

Tumor-Agnostic

Neoplasm Metastasis